Category: Clinical Breakthroughs
-
Higher Doses of Anti-Seizure Medications May Be Needed in Pregnancy
Higher doses of anti-seizure medications may be necessary during pregnancy, according to a recent study.
-
Teaching AI to Read Fetal Ultrasound in Low- and Middle-Income Countries
Northwestern Medicine and Google are collaborating on a project to bring fetal ultrasound to developing countries by combining AI (artificial intelligence), low-cost hand-held ultrasound devices and a smartphone.
-
Exposure to Artificial Light During Sleep May Increase Risk of Heart Disease and Diabetes
Exposure to even moderate ambient lighting during nighttime sleep, harms cardiovascular function during sleep and increases your insulin resistance, according to a new study.
-
First Potential Immunization Against RSV for Healthy Infants Found Highly Effective in Phase 3 Trial
A new drug has been shown to be highly effective against pediatrics infections caused by respiratory syncytial virus (RSV).
-
Glucocorticoids Enhance Muscles Through Sex-Specific Pathways
Glucocorticoid steroids improved muscle performance through distinct, sex-specific mechanisms, according to a Northwestern Medicine study.
-
Good Outcomes in COVID-19 Lung Transplants
Patients with COVID-19-associated lung disease who received lung transplants had similar outcomes compared to patients without COVID-19, according to a study published in JAMA.
-
Intensive Crohn’s Treatment is Safe
Intensive treatment for patients with Crohn’s disease showed no safety differences compared to the current standard of care.
-
Optimizing Balance of Treatments in Prostate Cancer
Patients receiving radiotherapy to treat high-risk prostate cancer benefit from androgen deprivation therapy, and length of treatment may be dependent on radiation deliver, according to a recent study.
-
New Treatment for Metastatic Hormone-Sensitive Prostate Cancer
The drug darolutamid, administered with standard androgen-deprivation therapy and docetaxel chemotherapy, increased survival in patients with metastatic hormone-sensitive prostate cancer.
-
Possible Third Cure To HIV: Progress in a Time of Regression
Associate vice president of research Richard D’Aquila, MD, shares his perspective on the news of a possible third person cured of HIV, and the progress of HIV research in the future.
